unknown
Stage
2019
Founded
2
Investors
About
Asher Bio develops cis-targeted immunotherapies that selectively activate specific immune cell types to improve efficacy and reduce side effects in cancer treatment.
Explore Asher Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.